Compare ANIP & OPRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANIP | OPRA |
|---|---|---|
| Founded | 2001 | 1996 |
| Country | United States | Norway |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 1999 | 2018 |
| Metric | ANIP | OPRA |
|---|---|---|
| Price | $85.19 | $19.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $110.00 | $21.50 |
| AVG Volume (30 Days) | 291.4K | ★ 334.6K |
| Earning Date | 05-08-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 4.61% |
| EPS Growth | ★ 419.23 | N/A |
| EPS | ★ 1.28 | N/A |
| Revenue | ★ $206,547,000.00 | N/A |
| Revenue This Year | $21.01 | $21.29 |
| Revenue Next Year | $17.59 | $15.34 |
| P/E Ratio | $66.23 | ★ $13.62 |
| Revenue Growth | ★ 2.47 | N/A |
| 52 Week Low | $62.61 | $11.71 |
| 52 Week High | $99.50 | $21.06 |
| Indicator | ANIP | OPRA |
|---|---|---|
| Relative Strength Index (RSI) | 58.25 | 54.85 |
| Support Level | $77.16 | $16.96 |
| Resistance Level | $87.42 | $19.43 |
| Average True Range (ATR) | 2.60 | 0.73 |
| MACD | 0.28 | 0.07 |
| Stochastic Oscillator | 75.84 | 55.28 |
ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.
Opera Ltd is a consumer internet software company providing a diversified portfolio of high-performance web browsers and adjacent digital services to engaged user base The company has transitioned from browser developer to multi-faceted platform offering a products and services that include PC and mobile browsers, its Opera Gaming portals and development tools, Opera News content platforms, Opera Ads platform, as well as a number of AI and web3 products and services, such as MiniPay and Opera AI, to a user base.